| Elizabeth Anne Hughes, LPC, QMHP | |
|
909 James St, Vermillion, SD 57069-1011 | |
| (605) 660-1315 | |
| Not Available |
| Full Name | Elizabeth Anne Hughes |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 909 James St, Vermillion, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215523006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LPC-MH-30597SUPV (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Anne Hughes, LPC, QMHP 909 James St, Vermillion, SD 57069-1011 Ph: (605) 660-1315 | Elizabeth Anne Hughes, LPC, QMHP 909 James St, Vermillion, SD 57069-1011 Ph: (605) 660-1315 |
News Archive
Financially strapped state and local governments are saving billions of dollars on health insurance by cutting back on free coverage for employees and raising worker contributions, a USA Today analysis finds. Government workers still enjoy more generous health benefits than privately employed workers but the advantage has narrowed from $1,523 in 2007 to $891 in 2012, adjusted for inflation, federal data show.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported that the U.S. Food and Drug Administration (FDA) has approved resuming clinical development of elesclomol, the Company's first-in-class oxidative stress inducer.
Just in time for the most dangerous days of the year to drive July 3 and 4 the national Center for Excellence in Rural Safety (CERS) at the University of Minnesota today released a list of the states where Americans are more likely to die in a traffic crash on a rural road.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
Nanomedicine is the medical application of nanotechnology, or the use of microscopic structures to diagnose, image, treat and prevent disease. Current problems in nanomedicine include understanding and anticipating the potentially toxic impact these nanostructures have on the body and the environment once they're released.
› Verified 4 days ago
Allison Walsh, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 21 Market St, Vermillion, SD 57069 Phone: 605-670-1040 Fax: 605-679-6603 | |
Cora Ann Youngberg, Counselor Medicare: Not Enrolled in Medicare Practice Location: 717 E Main St, Vermillion, SD 57069 Phone: 605-494-1500 | |
Wendy Eggen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 W Main St, Vermillion, SD 57069 Phone: 605-624-9148 | |
Mrs. Debra Kay Gapp, LPC-MH, LAC, QMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1120 Valley View Dr., Gapp Counseling Services, Vermillion, SD 57069 Phone: 605-677-9052 | |
Rachel Collette Bock, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 414 E Clark St, Noteboom Hall #117, Vermillion, SD 57069 Phone: 605-658-3720 |